BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease ...

BTIG maintained its Buy rating and $190.00 price target for FTAI Aviation (NASDAQ: FTAI), which has demonstrated strong revenue growth of 36.77% over the last twelve months, despite recent challenges ...

BTIG analyst David Larsen maintained a Buy rating on BrightSpring Health Services, Inc. (BTSG – Research Report) today and set a price target ...

BTIG raised the firm’s price target on CyberArk (CYBR) to $407 from $351 and keeps a Buy rating on the shares as part of a broader research ...

MGM Resorts International (MGM) stock saw a modest uptick, ending the day at $33.35 which represents a slight increase of $0.50 or 1.52% from the prior close of $32.85. The stock opened at $32.99 and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However ...

NEW YORK, January 17, 2025--(BUSINESS WIRE)--BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California.

BTIG initiated coverage of Cartesian Therapeutics (RNAC) with a Buy rating and $42 price target Cartesian is pioneering the field of mRNA-based CART cell therapies for autoimmune disorders ...

BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California. The funds will be donated to reputable organizations ...